Session

PP 05 IBD (Posters)

DATA IN A TERTIARY HOSPITAL ON SWITCHING FROM AN INTENSIFIED AND NON INTENSIFIED REGIMEN OF INTRAVENOUS VEDOLIZUMAB TO A SUBCUTANEOUS IN ADULTS WITH INFLAMMATORY BOWEL DISEASE
DATA IN A TERTIARY HOSPITAL ON SWITCHING FROM AN INTENSIFIED AND NON INTENSIFIED REGIMEN OF INTRAVENOUS VEDOLIZUMAB TO A SUBCUTANEOUS IN ADULTS WITH INFLAMMATORY BOWEL DISEASE

PP 05 IBD (Posters)  et al.

POSSIBLE THERAPEUTIC EFFECT OF HELIX POMATIA MUCUS ON AN EXPERIMENTALLY INDUCED MODEL OF ULCERATIVE COLITIS
POSSIBLE THERAPEUTIC EFFECT OF HELIX POMATIA MUCUS ON AN EXPERIMENTALLY INDUCED MODEL OF ULCERATIVE COLITIS

PP 05 IBD (Posters)  et al.

CELLULAR AND MOLECULAR IMPACT OF THE MELANOCORTIN RECEPTOR AGONIST PL8177 IN DEXTRAN SULFATE SODIUM–INDUCED COLITIS IN RATS
CELLULAR AND MOLECULAR IMPACT OF THE MELANOCORTIN RECEPTOR AGONIST PL8177 IN DEXTRAN SULFATE SODIUM–INDUCED COLITIS IN RATS

PP 05 IBD (Posters)  et al.

PERFORMANCE OF INTESTINAL ULTRASOUND SCORES IN DETECTING ACTIVE CROHN'S DISEASE
PERFORMANCE OF INTESTINAL ULTRASOUND SCORES IN DETECTING ACTIVE CROHN'S DISEASE

PP 05 IBD (Posters)  et al.

TREATMENT OF BONE MARROW MESENCHYMAL STROMAL CELLS REDUCES THE ACTIVITY ANKYLOSING SPONDYLITIS ASSOCIATED WITH CROHN'S DISEASE
TREATMENT OF BONE MARROW MESENCHYMAL STROMAL CELLS REDUCES THE ACTIVITY ANKYLOSING SPONDYLITIS ASSOCIATED WITH CROHN'S DISEASE

PP 05 IBD (Posters)  et al.

THE EFFECTIVENESS AND SAFENESS OF ALLOGENEIC MESENCHYMAL STROMAL CELLS OF BONE MARROW IN PATIENTS WITH REFRACTORY CROHN'S DISEASE - 10 YEARS OF OBSERVATION
THE EFFECTIVENESS AND SAFENESS OF ALLOGENEIC MESENCHYMAL STROMAL CELLS OF BONE MARROW IN PATIENTS WITH REFRACTORY CROHN'S DISEASE - 10 YEARS OF OBSERVATION

PP 05 IBD (Posters)  et al.

UPPER GASTROINTESTINAL TRACT INVOLVEMENT IN CROHN’S DISEASE: IMPACT ON CLINICAL PROFILE AND DISEASE COURSE
UPPER GASTROINTESTINAL TRACT INVOLVEMENT IN CROHN’S DISEASE: IMPACT ON CLINICAL PROFILE AND DISEASE COURSE

PP 05 IBD (Posters)  et al.

SAFETY AND EFFECTIVENESS OF COMBINING BIOLOGICS AND SMALL MOLECULES IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: AN UPDATED SYSTEMATIC REVIEW WITH METANALYSIS
SAFETY AND EFFECTIVENESS OF COMBINING BIOLOGICS AND SMALL MOLECULES IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: AN UPDATED SYSTEMATIC REVIEW WITH METANALYSIS

PP 05 IBD (Posters)  et al.

MICROSCOPIC COLITIS AND RISK OF INCIDENT PSORIASIS: A NATIONWIDE POPULATION-BASED MATCHED COHORT STUDY.
MICROSCOPIC COLITIS AND RISK OF INCIDENT PSORIASIS: A NATIONWIDE POPULATION-BASED MATCHED COHORT STUDY.

PP 05 IBD (Posters)  et al.

THE ROLE OF CHEST X-RAYS WHEN SCREENING FOR LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE BEFORE STARTING BIOLOGIC TREATMENT
THE ROLE OF CHEST X-RAYS WHEN SCREENING FOR LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE BEFORE STARTING BIOLOGIC TREATMENT

PP 05 IBD (Posters)  et al.

INTESTINAL ULTRASOUND IS RESPONSIVE TO TREATMENT IN NEWLY DIAGNOSED CROHN’S DISEASE
INTESTINAL ULTRASOUND IS RESPONSIVE TO TREATMENT IN NEWLY DIAGNOSED CROHN’S DISEASE

PP 05 IBD (Posters)  et al.

ETRASIMOD INDUCTION THERAPY IN MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: RESULTS FROM A PHASE 2, RANDOMISED, DOUBLE-BLIND SUBSTUDY
ETRASIMOD INDUCTION THERAPY IN MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: RESULTS FROM A PHASE 2, RANDOMISED, DOUBLE-BLIND SUBSTUDY

PP 05 IBD (Posters)  et al.

ARE RECTAL OR RECTOSIGMOID ENDOSCOPY SUFFICIENT TO ASSESS COMPLETE ENDOSCOPIC OR HISTOLOGICAL HEALING IN ULCERATIVE COLITIS: A CROSS-SECTIONAL STUDY
ARE RECTAL OR RECTOSIGMOID ENDOSCOPY SUFFICIENT TO ASSESS COMPLETE ENDOSCOPIC OR HISTOLOGICAL HEALING IN ULCERATIVE COLITIS: A CROSS-SECTIONAL STUDY

PP 05 IBD (Posters)  et al.

INFLAMMATORY BOWEL DISEASE IN THE LGBTIQ+ POPULATION: ESTIMATES OF PREVALENCE IN ENGLAND & WALES AND THE IMPLICATION FOR SERVICES
INFLAMMATORY BOWEL DISEASE IN THE LGBTIQ+ POPULATION: ESTIMATES OF PREVALENCE IN ENGLAND & WALES AND THE IMPLICATION FOR SERVICES

PP 05 IBD (Posters)  et al.

JAK INHIBITORS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: RESULTS OF AN INTERNATIONAL SURVEY OF PERCEPTIONS, ATTITUDES, AND CLINICAL PRACTICE
JAK INHIBITORS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: RESULTS OF AN INTERNATIONAL SURVEY OF PERCEPTIONS, ATTITUDES, AND CLINICAL PRACTICE

PP 05 IBD (Posters)  et al.

A RETROSPECTIVE ANALYSIS OF FAT COMPOSITION IN A COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
A RETROSPECTIVE ANALYSIS OF FAT COMPOSITION IN A COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

PP 05 IBD (Posters)  et al.

A GLOBAL CONSENSUS ON THE DEFINITIONS, DIAGNOSIS AND MANAGEMENT OF FIBROSTENOSING SMALL BOWEL CROHN'S DISEASE
A GLOBAL CONSENSUS ON THE DEFINITIONS, DIAGNOSIS AND MANAGEMENT OF FIBROSTENOSING SMALL BOWEL CROHN'S DISEASE

PP 05 IBD (Posters)  et al.

LONG-TERM VEDOLIZUMAB PERSISTENCE IN ULCERATIVE COLITIS: THE EDINBURGH IBD UNIT EXPERIENCE 2014-2022
LONG-TERM VEDOLIZUMAB PERSISTENCE IN ULCERATIVE COLITIS: THE EDINBURGH IBD UNIT EXPERIENCE 2014-2022

PP 05 IBD (Posters)  et al.

INTESTINAL ULTRASOUND – COLITIS SEVERITY INDEX (IUS-CSI): VALIDATION OF AN INTESTINAL ULTRASOUND-BASED SCORE FOR ASSESSING DISEASE ACTIVITY IN ULCERATIVE COLITIS
INTESTINAL ULTRASOUND – COLITIS SEVERITY INDEX (IUS-CSI): VALIDATION OF AN INTESTINAL ULTRASOUND-BASED SCORE FOR ASSESSING DISEASE ACTIVITY IN ULCERATIVE COLITIS

PP 05 IBD (Posters)  et al.

EFFICACY AND SAFETY OF ETRASIMOD IN PATIENTS WITH AND WITHOUT CONCOMITANT CORTICOSTEROID TREATMENT IN THE PHASE 3 ELEVATE UC 52 AND ELEVATE UC 12 TRIALS
EFFICACY AND SAFETY OF ETRASIMOD IN PATIENTS WITH AND WITHOUT CONCOMITANT CORTICOSTEROID TREATMENT IN THE PHASE 3 ELEVATE UC 52 AND ELEVATE UC 12 TRIALS

PP 05 IBD (Posters)  et al.

Item 161 - 180 / 826
1 2 3 4 5 6 7 8
9
10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42